Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
If your child has been diagnosed with Kasabach-Merritt phenomenon (KMP), a complication in which certain vascular tumors trap and destroy platelets, we understand that you are very concerned about your child’s health. You probably have a lot of questions about this complex condition and the vascular tumors that cause it.
Here’s what you need to know about Kasabach-Merritt phenomenon:
How Children’s Hospital Boston approaches Kasabach-Merritt phenomenon
Because Kasabach-Merritt phenomenon and the associated vascular tumors are so rare, we recommend that children with KMP be evaluated by an expert vascular anomalies center. In articles and on the web, KMP is confused with any blood test related to clotting or bleeding in a patient with a birthmark, hemangioma or vascular tumor. This is incorrect and leads to the wrong diagnosis and ineffective treatment plans in some cases.
Here at Children’s Vascular Anomalies Center, we have the world’s largest database of children whose vascular tumors have caused Kasabach-Merritt phenomenon. When doctors anywhere in the world have questions about whether a child’s birthmark may be a vascular tumor that could lead to Kasabach-Merritt phenomenon, they often call us. Our physicians have treated more children with Kasabach-Merritt phenomenon than any other hospital in the world—which means that your child will get expert care from experienced physicians.
Children’s Vascular Anomalies Center has the largest database in the world of children who have experienced Kasabach-Merritt phenomenon — currently more than 125 cases of vascular anomalies with KMP. As our database grows, it will help shine more light on this rare and often misunderstood condition.
Kasabach-Merritt phenomenon: Reviewed by Cameron C. Trenor III, MD,
© Children’s Hospital Boston, 2010
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”